{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T04:10:37Z","timestamp":1789963837421,"version":"4.0.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001823","name":"Ministerstvo \u0160kolstv\u00ed, Ml\u00e1de\u017ee a T\u011blov\u00fdchovy","doi-asserted-by":"publisher","award":["MSM 0021620814"],"award-info":[{"award-number":["MSM 0021620814"]}],"id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["CZE 03\/014"],"award-info":[{"award-number":["CZE 03\/014"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.humimm.2006.05.006","type":"journal-article","created":{"date-parts":[[2006,6,23]],"date-time":"2006-06-23T09:37:06Z","timestamp":1151055426000},"page":"706-713","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["NF\u03baB and Its Inhibitor I\u03baB in Relation to Type 2 Diabetes and Its Microvascular and Atherosclerotic Complications"],"prefix":"10.1016","volume":"67","author":[{"given":"Marianna","family":"Romzova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Hohenadel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"Kolostova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Pinterova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marketa","family":"Fojtikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarka","family":"Ruzickova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ctibor","family":"Dostal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Bosak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Rychlik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Cerna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2006.05.006_bib1","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1053\/beem.2001.0150","article-title":"Genetics of diabetic nephropathy","volume":"15","author":"Rippin","year":"2001","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.humimm.2006.05.006_bib2","first-page":"F765","article-title":"Reactive oxygen species: production and role in the kidney","volume":"251","author":"Baud","year":"1986","journal-title":"Am J Physiol"},{"key":"10.1016\/j.humimm.2006.05.006_bib3","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1210\/er.2001-0039","article-title":"Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes","volume":"23","author":"Evans","year":"2002","journal-title":"Endocr Rev"},{"key":"10.1016\/j.humimm.2006.05.006_bib4","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1046\/j.1525-1373.1999.d01-137.x","article-title":"AntioxidantsNFkappaB activation, and diabetogenesis","volume":"222","author":"Ho","year":"1999","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.humimm.2006.05.006_bib5","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nm1185","article-title":"IKK-beta links inflammation to obesity-induced insulin resistance","volume":"11","author":"Arkan","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.humimm.2006.05.006_bib6","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nm1166","article-title":"Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB","volume":"11","author":"Cai","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.humimm.2006.05.006_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2005.03.075","article-title":"Is NF-kappaB a culprit in type 2 diabetes?","volume":"332","author":"Chen","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.humimm.2006.05.006_bib8","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1126\/science.1061620","article-title":"Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of IKKbeta","volume":"293","author":"Yuan","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.humimm.2006.05.006_bib9","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1006\/geno.1995.1270","article-title":"The complete exon-intron structure of the 156-kb human gene NFKB1, which encodes the p105 and p50 proteins of transcription factors NF-kappa B and I kappa B-gamma: implications for NF-kappa B-mediated signal transduction","volume":"30","author":"Heron","year":"1995","journal-title":"Genomics"},{"key":"10.1016\/j.humimm.2006.05.006_bib10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s100380050125","article-title":"Isolation and radiation hybrid mapping of a highly polymorphic CA repeat sequence at the human nuclear factor kappa-beta subunit 1 (NFKB1) locus","volume":"44","author":"Ota","year":"1999","journal-title":"J Hum Genet"},{"key":"10.1016\/j.humimm.2006.05.006_bib11","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/sj.gene.6363776","article-title":"NFkappaB polymorphisms and susceptibility to type 1 diabetes","volume":"2","author":"Hegazy","year":"2001","journal-title":"Genes Immun"},{"key":"10.1016\/j.humimm.2006.05.006_bib12","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s001250051142","article-title":"Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative-stress sensitive transcription factor NF-kappaB","volume":"42","author":"Hofmann","year":"1999","journal-title":"Diabetologia"},{"key":"10.1016\/j.humimm.2006.05.006_bib13","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/biof.5520100211","article-title":"The role of oxidative stress and NF-kappaB activation in late diabetic complications","volume":"10","author":"Mohamed","year":"1999","journal-title":"Biofactors"},{"key":"10.1016\/j.humimm.2006.05.006_bib14","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF00307739","article-title":"Class I associations and frequencies of class II HLA-DRB alleles by RFLP analysis in children with rheumatoid-factor-negative juvenile chronic arthritis","volume":"13","author":"Brunner","year":"1993","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.humimm.2006.05.006_bib15","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/BF00332561","article-title":"A model for the role of HLA-DQ molecules in the pathogenesis of juvenile chronic arthritis","volume":"11","author":"Haas","year":"1991","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.humimm.2006.05.006_bib16","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/sj.gene.6363916","article-title":"Characterization of a nuclear-factor-kappa B (NFkappaB) genetic marker in type 1 diabetes (T1DM) families","volume":"3","author":"Gylvin","year":"2002","journal-title":"Genes Immun"},{"key":"10.1016\/j.humimm.2006.05.006_bib17","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1093\/humrep\/13.12.3326","article-title":"Studies on associations between human leukocyte antigen (HLA) class II alleles and antiphospholipid antibodies in Danish and Czech women with recurrent miscarriages","volume":"13","author":"Christiansen","year":"1998","journal-title":"Hum Reprod"},{"key":"10.1016\/j.humimm.2006.05.006_bib18","first-page":"241","article-title":"HLA class II gene frequency in a Czech population","volume":"42","author":"Loudova","year":"1996","journal-title":"Folia Biol (Praha)"},{"key":"10.1016\/j.humimm.2006.05.006_bib19","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1164\/ajrccm.152.2.7633707","article-title":"\u201cThe sarcoidosis map\u201d: a joint survey of clinical and immunogenetic findings in two European countries","volume":"152","author":"Martinetti","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.humimm.2006.05.006_bib20","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1399-0039.2005.00341.x","article-title":"Analysis of the functional NFKB1 promoter polymorphism in rheumatoid arthritis and systemic lupus erythematosus","volume":"65","author":"Orozco","year":"2005","journal-title":"Tiss Antigens"},{"issue":"Suppl 1","key":"10.1016\/j.humimm.2006.05.006_bib21","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1079\/BJN2001340","article-title":"Transcription factor NF-kappaB as a potential biomarker for oxidative stress","volume":"86","author":"van den","year":"2001","journal-title":"Br J Nutr"},{"key":"10.1016\/j.humimm.2006.05.006_bib22","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/76211","article-title":"The 3\u2032 untranslated region of messenger RNA: a molecular \u2019hotspot\u2019 for pathology?","volume":"6","author":"Conne","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.humimm.2006.05.006_bib23","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nm1166","article-title":"Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB","volume":"11","author":"Cai","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.humimm.2006.05.006_bib24","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.2337\/diabetes.51.7.2005","article-title":"Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha","volume":"51","author":"Itani","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.humimm.2006.05.006_bib25","doi-asserted-by":"crossref","first-page":"4854","DOI":"10.1073\/pnas.91.11.4854","article-title":"Tumor necrosis factor alpha inhibits signaling from the insulin receptor","volume":"91","author":"Hotamisligil","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.humimm.2006.05.006_bib26","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1055\/s-0029-1212086","article-title":"Mechanisms of TNF-alpha-induced insulin resistance","volume":"107","author":"Hotamisligil","year":"1999","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.humimm.2006.05.006_bib27","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1006\/smim.2000.0210","article-title":"The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling","volume":"12","author":"Karin","year":"2000","journal-title":"Semin Immunol"},{"key":"10.1016\/j.humimm.2006.05.006_bib28","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1365-2370.2004.00458.x","article-title":"CA microsatellite polymorphism of the nuclear factor kappa B1 gene in celiac disease","volume":"31","author":"Rueda","year":"2004","journal-title":"Eur J Immunogenet"},{"key":"10.1016\/j.humimm.2006.05.006_bib29","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0304-3835(02)00460-3","article-title":"Polymorphic variants of NFKB1 and its inhibitory protein NFKBIA, and their involvement in sporadic breast cancer","volume":"188","author":"Curran","year":"2002","journal-title":"Cancer Lett"},{"key":"10.1016\/j.humimm.2006.05.006_bib30","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s001250051336","article-title":"Association of MHC class I chain-related A (MIC-A) gene polymorphism with type I diabetes","volume":"43","author":"Gambelunghe","year":"2000","journal-title":"Diabetologia"},{"key":"10.1016\/j.humimm.2006.05.006_bib31","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0198-8859(02)00776-0","article-title":"MICA4\/HLA-DRB1*04\/TNF1 haplotype is associated with mixed connective tissue disease in Swedish patients","volume":"64","author":"Hassan","year":"2003","journal-title":"Hum Immunol"}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885906001480?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885906001480?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:48:41Z","timestamp":1759319321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885906001480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S0198885906001480"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2006.05.006","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NF\u03baB and Its Inhibitor I\u03baB in Relation to Type 2 Diabetes and Its Microvascular and Atherosclerotic Complications","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2006.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}